Using the Support Online Platform for Self-management Education of Adults Living With Type 1 Diabetes as Part of Usual Care or Independently: an Implementation Study

Status: Recruiting
Location: See all (4) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The investigators will conduct a trial to evaluate if an online training and support platform can help adults living with type 1 diabetes (T1D) in their diabetes self-management. Investigators will compare a group that has access to the Support platform through their usual medical care to a group that accesses the platform independently. The first group will be recruited through four participating clinics in the province of Quebec (Canada). The second group will be composed of adults living with T1D across Canada. Participants will have access to the platform for 12 months and will be asked to complete online questionnaires at the beginning and after 6 and 12 months, and share their glucose reader data with the research team. A subgroup of participants as well as healthcare professionals from the four clinics will be invited to participate in an individual interview aiming to understand the barriers and facilitators of integration Support in clinical care.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Diagnosis of T1D (including LADA - latent autoimmune diabetes in adults)

• Have access to Internet

• Use of an active email address

• Comprehension of English or French

• Live in Canada

Locations
Other Locations
Canada
Centre hospitalier de l'université de Montreal
RECRUITING
Montreal
Institut de recherches cliniques de Montréal
RECRUITING
Montreal
Centre hospitalier de Quebec, Université Laval
RECRUITING
Québec
Centre de médecine métabolique de Lanaudière
RECRUITING
Terrebonne
Contact Information
Primary
Anne-Sophie Brazeau, PhD
anne-sophie.brazeau@mcgill.ca
5143987848
Backup
amelie Roy-Fleming, MSc
amelie.roy-fleming@mcgill.ca
5147790749
Time Frame
Start Date: 2024-05-05
Estimated Completion Date: 2027-10
Participants
Target number of participants: 322
Treatments
Experimental: Support integrated in usual care
PWT1D participants will have access to Support as part of their regular care (their HCPs will use Support in their care). PWT1D participants in ARM 1 are followed in one of the 4 participating clinics either in-person or remotely or hybrid.
Active_comparator: Support through independent access
PWT1D participants will have access to Support, independently from their regular care (they may initiate discussion about the platform with their diabetes care team who might register themselves on the platform, but will not prompt to any specific section on the platform and will not receive any training about the platform). PWT1D participants in ARM 2 can be followed in any other clinics in Canada.
Related Therapeutic Areas
Sponsors
Collaborators: Centre Hospitalier de l'Universite Laval (CHUL), Institut de Recherches Cliniques de Montreal, Centre hospitalier de l'Université de Montréal (CHUM), Centre de médecine métabolique de Lanaudière
Leads: McGill University

This content was sourced from clinicaltrials.gov